decompensation

(redirected from Decompensated)
Also found in: Medical, Encyclopedia.

de·com·pen·sa·tion

 (dē′kŏm-pən-sā′shən)
n.
1. Medicine The inability of a bodily organ or system, especially the circulatory system, to maintain adequate physiological function in the presence of disease.
2. Psychology The inability to maintain defense mechanisms in response to stress, resulting in personality disturbance or psychological imbalance.

de·com′pen·sate′ v.

decompensation

(diːˌkɒmpɛnˈseɪʃən)
n
(Pathology) pathol the inability of an organ, esp the heart, to maintain its function due to overload caused by a disease

de•com•pen•sa•tion

(ˌdi kɒm pənˈseɪ ʃən)

n.
1. the inability of a diseased heart to compensate for its defect.
2. inability to maintain appropriate psychological defenses, resulting in neurotic or psychotic symptoms.
[1900–05]
de•com′pen•sate`, v.i. -sat•ed, -sat•ing.
Translations

de·com·pen·sa·tion

n. descompensación, inhabilidad del corazón para mantener una circulación adecuada.

decompensation

n (psych) descompensación f
Mentioned in ?
References in periodicals archive ?
The child was in decompensated septic shock with respiratory failure and multi-organ dysfunction.
Intercept Pharmaceuticals announced that the Ocaliva, obeticholic acid or OCA, Prescribing Information in the United States has been updated to reinforce appropriate dosing in primary biliary cholangitis, or PBC, patients with Child-Pugh Class B or C or decompensated cirrhosis.
These positive secondary findings came from a study of 66 patients at least 55-years old who had been discharged from hospitalization for acute decompensated heart failure.
Patients were categorized into Treatment naive, treatment experienced and decompensated chronic liver disease.
Renova Therapeutics plans to advance development of the stresscopin program as RT-400, a peptide infusion treatment for episodes of Acute Decompensated Heart Failure.
Objective: To compare the serum sodium levels in compensated (Child Pugh A) and decompensated cirrhosis (Child Pugh C) secondary to chronic viral hepatitis C.
In ASTRAL-4, patients with decompensated cirrhosis receiving Epclusa with RBV for 12 weeks achieved a high SVR12 rate (94%) compared to those who received Epclusa for 12 weeks or 24 weeks (83% and 86%, respectively).
Bristol-Myers Squibb Canada announced Health Canada's approval of Daklinza (daclatasvir), in combination with sofosbuvir (with or without ribavirin) for 12 weeks in the treatment of chronic hepatitis C (CHC) in adult patients with hepatitis C vims (HCV) genotypes 1,2 or 3 in three difficult-to-treat populations, including patients with HIV-1 co-infection, patients with compensated or decompensated cirrhosis and patients with HCV recurrence after liver transplantation.
J-ty was diagnosed with decompensated liver disease secondary to neonatal hepatitis at the Philippine General Hospital on May 18, 2015, just over four months after he was born.
The acquisition will give Bristol-Myers Squibb full rights to Cardioxyl's lead asset CXL-1427, a novel nitroxyl donor (prodrug) in Phase 2 clinical development as an intravenous treatment for acute decompensated heart failure.
ORLANDO--Three simple, routinely collected measurements together provide a lot of insight into the risk faced by community-dwelling patients hospitalized for acute decompensated heart failure, according to data collected from 3,628 patients at one U.
based Cardioxyl's lead asset CXL-1427, a novel nitroxyl drug that has entered Phase II clinical development as an intravenous treatment for acute decompensated heart failure.